Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration-Effect Data to Support Clinical Development
Xiang, H., Bender, B. C., Reyes, A. E., Merchant, M., Jumbe, N. L. S., Romero, M., Davancaze, T., Nijem, I., Mai, E., Young, J., Peterson, A., Damico-Beyer, L. A.Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-13-0260
Date:
September, 2013
File:
PDF, 770 KB
english, 2013